Influencing of resorption and side-effects of salicylic acid by complexing with beta-cyclodextrin.
After oral administration of 14C-labelled salicylic acid and its beta-cyclodextrin complex to rats, the blood radioactivity-level increases in the first 2 h than decreases. The blood level obtained with the inclusion complex is somewhat but not significantly lower than with free acid. Since the resorption of cyclodextrin is a considerably slower process, it is very likely that the resorption of salicylic acid take place in the form of free acid after dissociation of the complex. The urinary excretion cumulative curves show that the free salicylic acid is completely excreted, while about 10% of the salicylic acid administered in the form of complex is lost. The cyclodextrin complex formation increases the pK value of all hydroxy-benzoic acids. Direct observations reveals that complex formation decreases the stomach-irritating effect of salicylic acid. The ratio of radioactivity was nearly the same in the organs of animals treated by both free salicylic and cyclodextrin complex.
D000818:Animals; D003505:Cyclodextrins / Q000378:metabolism / Q000494:pharmacology*; D003912:Dextrins / Q000494:pharmacology*; D004058:Diffusion; D005260:Female; D007509:Irritants; D008297:Male; D011208:Powders; D051381:Rats; D012459:Salicylates / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D013213:Starch / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects; D014018:Tissue Distribution; D014961:X-Ray Diffraction; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D003912:Dextrins; D007509:Irritants; D011208:Powders; D012459:Salicylates; D047392:beta-Cyclodextrins; D013213:Starch; C031215:betadex